Elevation of serum immunoreactive pancreatic secretory trypsin inhibitor contents in various malignant diseases.
Serum immunoreactive pancreatic secretory trypsin inhibitor was significantly elevated in patients with malignant diseases. The immunoreactivity was also detected in various normal tissues.